Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Organic Cation Transporter 2 (OCT2), encoded by the SLC22A2 gene, is a polyspecific transporter primarily expressed in the kidney. It mediates the uptake of a wide range of organic cations, including drugs, toxins, and metabolites, across the cell membrane via facilitated diffusion. OCT2 plays a crucial role in renal drug handling and is a major determinant of pharmacokinetics for many drugs. Its broad substrate specificity leads to clinically relevant drug-drug interactions. Emerging evidence suggests potential roles in other tissues, such as the pancreas.
Inhibition of organic cation transport
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Organic Cation Transporter 2 (OCT2).